Rankings
▼
Calendar
VSTM (Verastem, Inc.) Stock Financials & Earnings | Market Cap Arena
VSTM
Verastem, Inc.
Mkt Cap
$388M
Healthcare
·
Biotechnology
·
🇺🇸 United States
·
NASDAQ
Revenue (TTM)
$31M
Net Income (TTM)
-$209M
EPS (TTM)
-$3.32
Free Cash Flow (TTM)
-$138M
Gross Margin
83.8%
Op. Margin
-550.3%
Net Margin
-677.6%
FCF Margin
-444.8%
P/S Ratio (TTM)
12.6x
P/E Ratio (TTM)
—
YoY Rev Growth
+209.1%
Employees
—
Earnings Reports
▶
Q4 2025
NEW
Browse All Reports
Quarterly
FY
Revenue & Profitability
Revenue
Gross Profit
Operating Income
Quarter
Revenue
Gross Profit
Op. Income
Q1 23
$0
$0
-$19M
Q2 23
$0
$0
-$20M
Q3 23
$0
$0
-$21M
Q4 23
$0
$0
-$31M
Q1 24
$0
$0
-$28M
Q2 24
$10M
$10M
-$18M
Q3 24
$0
$0
-$37M
Q4 24
$0
$0
-$32M
Q1 25
$0
$0
-$44M
Q2 25
$2M
$2M
-$44M
Q3 25
$11M
$10M
-$41M
Q4 25
$18M
$15M
-$41M
marketcaparena.com
Valuation
P/S Ratio
P/E Ratio
Quarter
P/S
P/E
Q1 23
—
—
Q2 23
—
—
Q3 23
—
—
Q4 23
—
—
Q1 24
—
—
Q2 24
38.8x
—
Q3 24
38.8x
—
Q4 24
38.8x
—
Q1 25
38.8x
—
Q2 25
181.8x
—
Q3 25
29.0x
—
Q4 25
12.6x
—
marketcaparena.com
Operating Cash Flow
Operating Cash Flow
Free Cash Flow
Quarter
Operating CF
Free CF
Q1 23
-$20M
-$20M
Q2 23
-$20M
-$20M
Q3 23
-$17M
-$17M
Q4 23
-$30M
-$30M
Q1 24
-$28M
-$28M
Q2 24
-$28M
-$28M
Q3 24
-$24M
-$24M
Q4 24
-$25M
-$25M
Q1 25
-$39M
-$39M
Q2 25
-$33M
-$33M
Q3 25
-$36M
-$36M
Q4 25
-$30M
-$30M
marketcaparena.com
Capital Expenditures
CapEx
Quarter
CapEx
Q1 23
$0
Q2 23
$0
Q3 23
$0
Q4 23
$0
Q1 24
$21K
Q2 24
$7K
Q3 24
$0
Q4 24
$0
Q1 25
$0
Q2 25
$0
Q3 25
$0
Q4 25
$0
marketcaparena.com
OpEx vs Revenue Growth (YoY)
Revenue Growth
OpEx Growth
Quarter
Revenue Growth
OpEx Growth
Q1 23
-100.0%
-1.2%
Q2 23
—
-5.2%
Q3 23
—
+20.3%
Q4 23
—
+84.8%
Q1 24
—
+45.1%
Q2 24
—
+39.4%
Q3 24
—
+73.8%
Q4 24
—
+1.4%
Q1 25
—
+57.4%
Q2 25
-78.6%
+62.3%
Q3 25
—
+40.3%
Q4 25
—
+86.8%
marketcaparena.com
Stock-Based Compensation
SBC ($)
% of Revenue
Quarter
SBC ($)
% of Revenue
Q1 23
$1M
—
Q2 23
$1M
—
Q3 23
$2M
—
Q4 23
$2M
—
Q1 24
$1M
—
Q2 24
$2M
19.1%
Q3 24
$2M
—
Q4 24
$2M
—
Q1 25
$2M
—
Q2 25
$3M
159.7%
Q3 25
$2M
19.4%
Q4 25
$2M
11.5%
marketcaparena.com
OpEx Breakdown
R&D
SG&A
Quarter
R&D
SG&A
Q1 23
$12M
$7M
Q2 23
$13M
$7M
Q3 23
$14M
$7M
Q4 23
$23M
$9M
Q1 24
$18M
$10M
Q2 24
$18M
$10M
Q3 24
$25M
$12M
Q4 24
$21M
$11M
Q1 25
$29M
$15M
Q2 25
$25M
$21M
Q3 25
$29M
$21M
Q4 25
$32M
$24M
marketcaparena.com
Revenue Segments
Quarter
marketcaparena.com
War Chest
Cash & Equivalents
Short-Term Investments
Quarter
Cash
Short-term Investments
Total
Q1 23
$97M
$14M
$111M
Q2 23
$183M
$0
$183M
Q3 23
$95M
$71M
$166M
Q4 23
$78M
$59M
$137M
Q1 24
$81M
$29M
$110M
Q2 24
$83M
$0
$83M
Q3 24
$113M
$0
$113M
Q4 24
$89M
$0
$89M
Q1 25
$118M
$0
$118M
Q2 25
$164M
$0
$164M
Q3 25
$138M
$0
$138M
Q4 25
$205M
$0
$205M
marketcaparena.com
Shares Outstanding
Shares Outstanding
Quarter
Shares (Diluted)
QoQ Change
Q1 23
17M
-1.9%
Q2 23
18M
+6.0%
Q3 23
27M
+51.1%
Q4 23
27M
+0.1%
Q1 24
27M
+0.1%
Q2 24
27M
+0.1%
Q3 24
40M
+49.9%
Q4 24
38M
-5.6%
Q1 25
54M
+42.6%
Q2 25
74M
+36.7%
Q3 25
73M
-1.2%
Q4 25
83M
+14.0%
marketcaparena.com
Revenue Per Employee
Revenue / Employee
Year
Revenue/Employee
Employees
FY 14
$0
47
FY 15
$0
22
FY 16
$0
32
FY 17
$0
69
FY 18
$158K
169
FY 19
$129K
135
FY 20
$2M
48
FY 21
$43K
48
FY 22
$46K
57
FY 23
$0
73
FY 24
$128K
78
FY 25
$461
67K
marketcaparena.com